Related Articles
Impact of post‑operative hormone replacement therapy on life quality and prognosis in patients with ovarian malignancy
The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development
Receptor status variation in primary breast cancer and subsequent accessible relapse
Estrogen metabolism genotypes, use of long-term hormone replacement therapy and risk of postmenopausal breast cancer
A case-control study of uterine endometrial cancer of pre- and post-menopausal women.